Dr. Michael S. Benjamin, MD

Dr. Benjamin practices at Premiere Outpatient Surgery Center Corp in West Hills, California.

Dr. Benjamin's NPI, 1619933132, was assigned on April 24, 2006. Dr. Benjamin graduated from Tulane University School of Medicine in 1998. Dr. Benjamin holds California license A86460.

Dr. Benjamin's primary practice is Premiere Outpatient Surgery Center Corp, at 7325 N Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 884-9944.

Dr. Benjamin's primary practice is Premiere Outpatient Surgery Center Corp in West Hills, California. Dr. Benjamin is also affiliated with UCLA West Valley Medical Center. The medical group on file is Michael Benjamin MD Inc. Dmand AI also links Dr. Benjamin to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benjamin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Benjamin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Benjamin is licensed in California.

CMS data shows 41,784 Medicare services from Dr. Benjamin across 25 procedure codes in 2024, for 401 Medicare patients. Medicare paid $363,499 for them.

CMS counts 401 Medicare patients who saw Dr. Benjamin in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benjamin's median patient age at 69, with 62% women.

In 2024, Dr. Benjamin wrote 1,835 Medicare Part D claims for 225 patients. 16% of them were for generic drugs. CMS names the drug for 1,622 of them, across 32 drugs with 11 or more claims each, at $11,407,813 in total drug cost. In 2023, CMS named 1,086 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Benjamin for performance year 2024, reported individually. Dr. Benjamin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benjamin as offering telehealth.

Dmand AI links 5 papers to Dr. Benjamin, published from 2017 to 2019. The most frequent topics are HIV Infections, Black or African American and Sexual and Gender Minorities.

CMS Open Payments shows 926 general payments to Dr. Benjamin from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Celgene Corporation paid the most, $4,058.

Dr. Benjamin graduated from Tulane University School of Medicine in 1998.